Ebola vaccine: Promising phase I trials
(German Center for Infection Research) The clinical phase I trial of a potential vaccine against the dreaded Ebola virus has been successfully completed at four partner sites in Africa and Europe. The safety of the tested vaccine 'rVSV-ZEBOV', which induces persistent antibodies against the virus, has been confirmed. The results are currently published in the New England Journal of Medicine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 3, 2016 Category: Infectious Diseases Source Type: news

NewLink Genetics receives contract option from BARDA to develop Ebola vaccine
The Biomedical Advanced Research and Development Authority (BARDA) of the US Department of Health and Human Services (HHS) has awarded a $21.6m contract option to NewLink Genetics. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 26, 2016 Category: Pharmaceuticals Source Type: news

Rwanda: Rwanda Plans Yellow Fever, Zika Vaccination
[East African] Rwanda plans mass vaccination for yellow fever, Zika virus, Rift Valley fever and Ebola after neighbouring countries reported cases of the diseases. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 25, 2016 Category: African Health Source Type: news

Is U.S. prepared for next disease outbreak?
The world was pretty far from having a vaccine for Ebola when the virus ravaged West Africa in 2014 and 2015. But it might have been a little closer if the United States had not cut funding for research on a promising new Ebola vaccine in 2012. (Source: WDSU.com - Health)
Source: WDSU.com - Health - April 20, 2016 Category: Consumer Health News Source Type: news

Ebola Vaccine Candidates Demonstrate Safety and Immune Response (FREE)
By Kelly Young Edited by Lorenzo Di Francesco, MD, FACP, FHM Two potential vaccines against Ebola appear to be safe and induce an immune response, researchers report in JAMA.In a phase I … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 20, 2016 Category: Primary Care Source Type: news

Cuts could leave U.S. unprepared for disease outbreak, report warns
The world was pretty far from having a vaccine for Ebola when the virus ravaged West Africa in 2014 and 2015. But it might have been a little closer if the United States had not cut funding for research on a promising new Ebola vaccine in 2012, according to a report by the Global Health Technologies Coalition. (Source: CNN.com - Health)
Source: CNN.com - Health - April 19, 2016 Category: Consumer Health News Source Type: news

Two-Step Ebola Vaccine Works in Early Trial
But one expert says two shots might be hard to give in an outbreak setting (Source: WebMD Health)
Source: WebMD Health - April 19, 2016 Category: Consumer Health News Source Type: news

Study examines safety, immune response of candidate Ebola vaccines
A phase 1 trial has been conducted to evaluate the tolerability and immunogenicity of two candidate Ebola vaccines, an adenovirus type 26 vector vaccine (Ad26.ZEBOV), and a modified Ankara vector vaccine (MVA-BN-Filo). (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 19, 2016 Category: Science Source Type: news

Two-Step Ebola Vaccine Strategy Works in Early Trial
But one expert says two shots might be hard to give in an outbreak setting (Source: U.S. News - Health)
Source: U.S. News - Health - April 19, 2016 Category: Consumer Health News Source Type: news

Two-Step Ebola Vaccine Strategy Works in Early Trial
But one expert says two shots might be hard to give in an outbreak setting Source: HealthDay Related MedlinePlus Pages: Ebola, Immunization (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 19, 2016 Category: Consumer Health News Source Type: news

Two-Step Ebola Vaccine Strategy Works in Early Trial
TUESDAY, April 19, 2016 -- A new two-step Ebola vaccine strategy has shown some promise in early clinical trials. The trials involved two candidate Ebola vaccines that were given to volunteers in separate shots, the researchers said. One vaccine... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 19, 2016 Category: Journals (General) Source Type: news

Two-vaccine Ebola regimen shows promise in early-stage clinical trial
An immunization regimen using two Ebola vaccine candidates was safe and well-tolerated and induced an immune response in healthy adult volunteers in a Phase 1 clinical trial. Results from the study are described in the April 19th issue of the Journal of the American Medical Association. (Source: World Pharma News)
Source: World Pharma News - April 19, 2016 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Two-vaccine Ebola regimen shows promise in early-stage clinical trial
(NIH/National Institute of Allergy and Infectious Diseases) An immunization regimen using two Ebola vaccine candidates was safe, well-tolerated and induced an immune response in healthy adult volunteers in a Phase 1 clinical trial. Results from the study are described in the April 19th issue of the Journal of the American Medical Association. NIAID has supported the development and testing of the two investigational vaccines: Ad26.ZEBOV, developed by Crucell Holland B.V., and MVA-BN-Filo, developed by Bavarian Nordic. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2016 Category: Global & Universal Source Type: news

Study examines safety, immune response of candidate Ebola vaccines
(The JAMA Network Journals) In a study appearing in the April 19, 2016 issue of JAMA, Matthew D. Snape, F.R.C.P.C.H., M.D., of the University of Oxford, United Kingdom, and colleagues conducted a phase 1 trial to evaluate the tolerability and immunogenicity of two candidate Ebola vaccines, an adenovirus type 26 vector vaccine (Ad26.ZEBOV), and a modified Ankara vector vaccine (MVA-BN-Filo). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 19, 2016 Category: Infectious Diseases Source Type: news

Ring Vaccination as Control Strategy for Ebola Virus DiseaseRing Vaccination as Control Strategy for Ebola Virus Disease
Is ring vaccination an effective strategy for controlling outbreaks of Ebola virus? Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 14, 2016 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

The Zika Virus Lesson? A New Approach Is Needed to Combat Pandemics
The Zika virus attracted many headlines this winter, but a recent admission by the chief medical officer at a leading vaccine manufacturer -- that the world is ill-prepared to deal with pandemic outbreaks -- underscores a fundamental problem. To ensure safety and efficacy, the federal government's regulatory approval process for new vaccines may extend development timelines for years. So when The New York Times reports that "eighteen organizations are working on developing a vaccine for the Zika virus," it is likely that those companies will labor for a very long time. Vaccinations rightly require stri...
Source: Science - The Huffington Post - April 12, 2016 Category: Science Source Type: news

U.S. Officials Warn Zika 'Scarier' Than Initially Thought
By Timothy Gardner and Jeff Mason WASHINGTON (Reuters) - Top health officials expressed heightened concern on Monday about the threat posed to the United States by the Zika virus, saying the mosquito that spreads it is now present in about 30 states and hundreds of thousands of infections could appear in Puerto Rico. At a White House briefing, they stepped up pressure on the Republican-led Congress to pass approximately $1.9 billion in emergency funding for Zika preparedness that the Obama administration requested in February. "Everything we look at with this virus seems to be a bit scarier than we initially thought,&...
Source: Healthy Living - The Huffington Post - April 12, 2016 Category: Consumer Health News Source Type: news

Zika Interview: "Virus May Create Outbreaks In Europe, The U.S. And Asia In The Future"
Associated with grave birth defects, the Zika virus tearing across Latin America could eventually affect more than half of the world's population. That's according to the London School of Hygiene & Tropical Medicine which agreed to an interview via email. Although the current epidemic in the Americas is being spread by the Aedes aegypti mosquito, according to Jimmy Whitworth, the School's Professor of International Public Health: "A number of mosquitos have been documented to carry the Zika virus. For example, the Aedes albopictus mosquito which resides in large parts of the U.S., southern Europe, and Asia is o...
Source: Healthy Living - The Huffington Post - April 11, 2016 Category: Consumer Health News Source Type: news

Last hope for great apes is vaccination against the rapid onslaught of disease
Scientists warn that wild ape populations, already devastated by poachers and habitat loss, now face a new threat from Ebola and other virusesVaccine campaigns to protect wild chimpanzees, gorillas and orang-utans could be the only hope of preventing the planet’s remaining great apes from suffering catastrophic population crashes, scientists have warned.They say that recent surveys of several populations of great apes have revealed devastating drops in numbers and that protective steps must now be taken as a matter of urgency. Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 10, 2016 Category: Science Authors: Robin McKie Tags: Endangered species Environment Animals World news Conservation Ebola Wildlife Primatology Science Africa Source Type: news

Designing Efficacious Vesicular Stomatitis Virus-Vectored Vaccines Against Ebola Virus
Infection with the Ebola virus (EBOV) causes an aggressive hemorrhagic disease in humans and nonhuman primates. Traditional approaches, such as vaccination with inactivated virion preparations, have had limited efficacy, whereas immunization with live-attenuated EBOV is not feasible due to the highly lethal nature of the pathogen. This has necessitated the development of other approaches towards an effective EBOV vaccine. Over the past decade, recombinant viruses expressing the EBOV glycoprotein (GP) have constituted the most promising platforms, as evidenced by their ability to protect naïve nonhuman primates from a ...
Source: Springer protocols feed by Immunology - April 9, 2016 Category: Allergy & Immunology Source Type: news

The Rise of Zika
By Drs. David Niesel and Norbert Herzog, Medical Discovery News Have you noticed in the past few years, we seem to be continuously assaulted by microbial menaces? Some years back it was SARS, which set off a global panic. People were screened for fevers at many major international airports. Then came the West Nile virus, which started from a single case in New York and in a matter of years marched across the U.S. Who can forget the avian flu or swine flu, which happened around the same time? More recently, the MERS virus has emerged, with outbreaks in the Arabian Peninsula and then whole villages in Korea. We are just now ...
Source: Science - The Huffington Post - April 6, 2016 Category: Science Source Type: news

The Rise of Zika
By Drs. David Niesel and Norbert Herzog, Medical Discovery News Have you noticed in the past few years, we seem to be continuously assaulted by microbial menaces? Some years back it was SARS, which set off a global panic. People were screened for fevers at many major international airports. Then came the West Nile virus, which started from a single case in New York and in a matter of years marched across the U.S. Who can forget the avian flu or swine flu, which happened around the same time? More recently, the MERS virus has emerged, with outbreaks in the Arabian Peninsula and then whole villages in Korea. We are just now...
Source: Science - The Huffington Post - April 6, 2016 Category: Science Source Type: news

Sleeping With Ebola
By Drs. David Niesel and Norbert Herzog, Medical Discovery News When you get sick, how do you know when it's safe to come into contact with other people without spreading the infection? For many infections such as influenza, you get sick one to four days after being exposed, and you can spread the virus for an additional five to seven days after becoming sick. Now consider the importance of that timeline when it comes to a deadly virus like Ebola. The 2015 Ebola outbreak in West Africa has been declared over, but we may need to rethink that conclusion. Ebola causes an acute illness that has a high mortality rate. People be...
Source: Science - The Huffington Post - April 6, 2016 Category: Science Source Type: news

Sleeping With Ebola
By Drs. David Niesel and Norbert Herzog, Medical Discovery News When you get sick, how do you know when it's safe to come into contact with other people without spreading the infection? For many infections such as influenza, you get sick one to four days after being exposed, and you can spread the virus for an additional five to seven days after becoming sick. Now consider the importance of that timeline when it comes to a deadly virus like Ebola. The 2015 Ebola outbreak in West Africa has been declared over, but we may need to rethink that conclusion. Ebola causes an acute illness that has a high mortality rate. People ...
Source: Science - The Huffington Post - April 6, 2016 Category: Science Source Type: news

South Africa: Never Mind Zika and Ebola - It's Yellow Fever We Should Be Worried About
[Daily Maverick] There is no medical reason why anyone should contract Yellow Fever today. But although an effective vaccine exists, a deadly new outbreak in Angola - 178 people have died, and counting - shows that not enough people are getting it in time. If we're not careful, and if we don't act quickly, this could be the beginning of a public health emergency on a par with Ebola or the Zika virus. By SIMON ALLISON. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 6, 2016 Category: African Health Source Type: news

New Ebola case reported in Liberia
That's the reality Friday in the fight against Ebola, with the World Health Organization announcing first that hundreds would get experimental vaccines in Guinea, then a short time later that the deadly disease has reemerged in Liberia. (Source: WDSU.com - Health)
Source: WDSU.com - Health - April 4, 2016 Category: Consumer Health News Source Type: news

Ebola Death in Liberia, Guinea Trying Experimental Vaccine (FREE)
By the Editors A 30-year-old woman in Liberia died from Ebola late last week. It's the third time the virus has resurfaced there since … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 4, 2016 Category: Primary Care Source Type: news

As Ebola flares up, Guinea plans to vaccinate contacts of survivors
CONAKRY/MONROVIA (Reuters) - Guinea will soon vaccinate people who have come into contact with more than 500 men who have recovered from Ebola, a senior health official said, the first time it has vaccinated the contacts of survivors. (Source: Reuters: Health)
Source: Reuters: Health - April 2, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Liberia: UN Reports New Ebola Case As Experimental Vaccine Used in Guinea
[UN News] Lab results confirmed a new case of the Ebola virus in Liberia, the United Nations health agency today announced, while an experimental vaccine against the virus is being used in parts of Guinea to contain the latest flare-up of the virus in that country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 2, 2016 Category: African Health Source Type: news

Experts Warn Complacency on Ebola May Leave Vaccine Work UnfinishedExperts Warn Complacency on Ebola May Leave Vaccine Work Unfinished
The World Health Organization (WHO) has declared the Ebola emergency over, but action is still needed to fully develop effective vaccines and prepare the world for future outbreaks, experts said on Thursday. Reuters Health Information (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - April 1, 2016 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Ebola R&D (Research and Development): Landscape of Clinical Candidates and Trials
World Health Organization. 10/2015This 34-page report presents information on candidate vaccines, therapies, and medical devices for Ebola, and gives an overview of completed and ongoing trials. It aims to contribute to greater transparency in medical research, and provides a guide to categories for clinical-stage vaccines, and a summary of candidate information for vaccines that have progressed past Phase 1 trials. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 1, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

New Ebola Case Confirmed in Liberia; Guinea Tries a Vaccine
Although the World Health Organization no longer considers Ebola an international emergency, new cases in Liberia and Guinea show the disease’s resilience. (Source: NYT Health)
Source: NYT Health - April 1, 2016 Category: Consumer Health News Authors: RICK GLADSTONE Tags: Liberia Guinea Ebola Virus Sierra Leone World Health Organization Source Type: news

Plotting the Course of Ebola Vaccines: Challenges and Unanswered Questions
University of Minnesota, Center for Infectious Disease Research and Policy. 03/31/2016This 33-page report discusses the renewed commitment from the global public health community that is needed to make progress toward getting vaccines for Ebola approved. It focuses on vaccine safety and efficacy, regulatory pathways for Ebola vaccines, input from African experts, and the business case for ongoing Ebola vaccine development and deployment. It offers eight recommendations, including completing clinical trials for as many vaccines as is feasible, gearing up for what studies to conduct during the next outbreak, and strengthenin...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 1, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

Health Highlights: April 1, 2016
Ebola Flare-Up in Liberia, Hundreds to Receive Experimental Vaccine in Guinea: WHO Lab Worker Salmonella Infection Being Investigated by CDC Medicare Tests New Payment System for Knee and Hip Replacements (Source: U.S. News - Health)
Source: U.S. News - Health - April 1, 2016 Category: Consumer Health News Source Type: news

Hundreds in Guinea get Ebola vaccine in fight against flare-up
LONDON (Reuters) - Hundreds of possible contacts of eight people infected with Ebola in Guinea have been vaccinated with an experimental Merck vaccine to try and halt a flare-up of the deadly disease, the World Health Organization said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - April 1, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Ebola: UN health agency reports new case in Liberia, as experimental vaccine used in Guinea
Lab results confirmed a new case of the Ebola virus in Liberia, the United Nations health agency today announced, while an experimental vaccine against the virus is being used in parts of Guinea to contain the latest flare-up of the virus in that country. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - April 1, 2016 Category: Global & Universal Source Type: news

Ebola R&D: Landscape of Clinical Candidates and Trials
World Health Organization. 10/2015This 34-page report presents information on candidate vaccines, therapies, and medical devices for Ebola, and gives an overview of completed and ongoing trials. It aims to contribute to greater transparency in medical research, and provides a guide to categories for clinical-stage vaccines, and a summary of candidate information for vaccines that have progressed past Phase 1 trials. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 1, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

Experts warn complacency on Ebola may leave vaccine work unfinished
LONDON (Reuters) - The World Health Organization (WHO) has declared the Ebola emergency over, but action is still needed to fully develop effective vaccines and prepare the world for future outbreaks, experts said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - March 31, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Montco firm reports early success with experimental Ebola vaccine
Inovio Pharmaceuticals Inc. reported on Tuesday positive results from early-stage testing of its experimental Ebola vaccine. The Plymouth Meeting, Pa., company’s phase-I clinical trial results came a day after the World Health Organization declared the Ebola outbreak that began in West Africa is no longer a public health emergency of international concern. That doesn’t mean work on vaccines and treatments for future outbreaks will stop. WHO said about 11,320 people — mostly living in Guinea,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 30, 2016 Category: Pharmaceuticals Authors: John George Source Type: news

Going Back To The Old Whooping Cough Vaccine Could Save Lives
By: Rachael Rettner  Published: 03/29/2016 11:01 AM EDT on LiveScience Newer isn't always better — some researchers are proposing to bring back an older version of the whooping cough vaccine, because multiple studies show that today's version doesn't protect as well as the earlier kind. In a new study, researchers suggest vaccinating children with one dose of the older whooping cough vaccine — called the whole-cell pertussis vaccine — and then giving them four doses of the current whooping cough vaccine in early childhood. (Whooping cough is also known as pertussis.) Currently, children are given fiv...
Source: Science - The Huffington Post - March 30, 2016 Category: Science Source Type: news

CDC Media Statement on World TB Day 2016
(function(){var src_url="https://spshared.5min.com/Scripts/PlayerSeed.js?playList=519608076&height=&width=100&sid=577&origin=undefined&videoGroupID=155847&relatedNumOfResults=100&responsive=true&ratio=wide&align=center&relatedMode=2&relatedBottomHeight=60&companionPos=&hasCompanion=false&autoStart=false&colorPallet=%23FFEB00&videoControlDisplayColor=%23191919&shuffle=0&isAP=1&pgType=cmsPlugin&pgTypeId=grabCodeLightbox&onVideoDataLoaded=HPTrack.Vid.DL&onTimeUpdate=HPTrack.Vid.TC";if (typeof(commercial_video) == "object&quo...
Source: Healthy Living - The Huffington Post - March 24, 2016 Category: Consumer Health News Source Type: news

He Looks At Tuberculosis Death Toll And Wonders Why You're Not Worried
Aaron Motsoaledi is tired of delivering the same spiel over and over again. No matter how many times the charismatic health minister of South Africa speaks out, people don’t seem to grasp the threat presented by tuberculosis, now the No. 1 infectious killer in the world. “People think it’s a curable disease that’s been there for ages, so what’s new? I think that’s the mentality,” Dr. Motsoaledi told The Huffington Post. As chair of the Stop TB Partnership, a group of public and private leaders hosted through the United Nations Office for Project Service, he has seen the eyes o...
Source: Science - The Huffington Post - March 24, 2016 Category: Science Source Type: news

7 Expert-Backed Tips For Staying Healthy On Your Next Big Trip
As spring approaches, you may be thinking about this year’s summer getaway. Or maybe you’re an Type A planner who is already booking a Thanksgiving or Christmas trip. Whatever your travel style, here's something you probably haven't considered: How to stay healthy while abroad. While you probably won’t make a Pinterest board of vaccinations with the same enthusiasm as you pin must-eat pastries and stylish travel outfits, taking care of your health on a trip might just save your life. Here are seven tips to help keep your vacations as stress- and sickness-free as possible:  1. First, call your doctor....
Source: Healthy Living - The Huffington Post - March 23, 2016 Category: Consumer Health News Source Type: news

Pharmaceutical PPPs And China's Contribution To Global Health Security
One of the major challenges in developing new medical countermeasures against threats to global health security—be it a new flu pandemic or rapid spread of a neglected disease—is the lack of an underlying commercial market to support the financial investment needed for expeditious drug development and scale-up. This challenge was demonstrated at the outset of the 2014 Ebola outbreak: even though the lethal virus was known for nearly 40 years, there was no cure or vaccine on the market. Paradoxically, while political attention to global health issues has revved up since the Ebola outbreak, funding is as short as...
Source: Forbes.com Healthcare News - March 22, 2016 Category: Pharmaceuticals Authors: Yanzhong Huang Source Type: news

China's Contribution To Global Health Security Through Pharma Partnerships
One of the major challenges in developing new medical countermeasures against threats to global health security—be it a new flu pandemic or rapid spread of a neglected disease—is the lack of an underlying commercial market to support the financial investment needed for expeditious drug development and scale-up. This challenge was demonstrated at the outset of the 2014 Ebola outbreak: even though the lethal virus was known for nearly 40 years, there was no cure or vaccine on the market. Paradoxically, while political attention to global health issues has revved up since the Ebola outbreak, funding is as short as...
Source: Forbes.com Healthcare News - March 22, 2016 Category: Pharmaceuticals Authors: Yanzhong Huang Source Type: news

[Report] Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Ebola virus disease in humans is highly lethal, with case fatality rates ranging from 25 to 90%. There is no licensed treatment or vaccine against the virus, underscoring the need for efficacious countermeasures. We ascertained that a human survivor of the 1995 Kikwit Ebola virus disease outbreak maintained circulating antibodies against the Ebola virus surface glycoprotein for more than a decade after infection. From this survivor we isolated monoclonal antibodies (mAbs) that neutralize recent and previous outbreak variants of Ebola virus and mediate antibody-dependent cell-mediated cytotoxicity in vitro. Strikingly, mono...
Source: ScienceNOW - March 17, 2016 Category: Science Authors: Davide Corti Source Type: news

[Report] Structural and molecular basis for Ebola virus neutralization by protective human antibodies
Ebola virus causes hemorrhagic fever with a high case fatality rate for which there is no approved therapy. Two human monoclonal antibodies, mAb100 and mAb114, in combination, protect nonhuman primates against all signs of Ebola virus disease, including viremia. Here, we demonstrate that mAb100 recognizes the base of the Ebola virus glycoprotein (GP) trimer, occludes access to the cathepsin-cleavage loop, and prevents the proteolytic cleavage of GP that is required for virus entry. We show that mAb114 interacts with the glycan cap and inner chalice of GP, remains associated after proteolytic removal of the glycan cap, and ...
Source: ScienceNOW - March 17, 2016 Category: Science Authors: John Misasi Source Type: news

To Your Health: NLM update:
Listen to the To Your Health: NLM update on Ebola's lost opportunities? The transcript is also available. While one clinical trial of an Ebola vaccine reported initial success, the findings from a dozen other vaccine trials have yet to be reported in leading medical journals and suggest a lost research opportunity, finds a recent story in Science. (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - March 8, 2016 Category: Consumer Health News Source Type: news

To Your Health: NLM update: Ebola's lost opportunities?
Listen to the To Your Health: NLM update on Ebola's lost opportunities? The transcript is also available. While one clinical trial of an Ebola vaccine reported initial success, the findings from a dozen other vaccine trials have yet to be reported in leading medical journals and suggest a lost research opportunity, finds a recent story in Science. (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - March 7, 2016 Category: Consumer Health News Source Type: news

2016 World Vaccine Congress: Breakthroughs for Ebola, Zika & Cancer Vaccines
Experts from Merck, GSK, Pfizer, Sanofi Pasteur and more to debate breakthroughs for vaccines for Ebola, Zika and cancer (Source: Disabled World)
Source: Disabled World - March 7, 2016 Category: Disability Tags: Events Source Type: news